Literature DB >> 1567129

Buerger's disease and cigarette smoking in Bangladesh.

W J Grove1, G P Stansby.   

Abstract

Buerger's disease is rare in the West but common in parts of Asia and the Middle East. A total of 39 patients with Buerger's disease were investigated in the setting of a hospital in Bangladesh. All but one were male and the mean age at onset of symptoms was 34 years. All but two were current smokers with a mean duration of smoking history of 17 years before the onset of symptoms. No other risk factors were identified. The majority of patients had ulceration or gangrene at presentation, and all but one had palpable femoral pulses. Vascular reconstruction was not possible in this institution and the main treatment options adopted were antibiotics, analgesia, chemical sympathectomy and amputation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567129      PMCID: PMC2497513     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  6 in total

1.  A critical evaluation of thromboangitis obliterans. The case against Buerger's disease.

Authors:  S WESSLER; S C MING; V GUREWICH; D G FREIMAN
Journal:  N Engl J Med       Date:  1960-06-09       Impact factor: 91.245

2.  Association of HLA-A9 and HLA-B5 with Buerger's disease.

Authors:  G A McLoughlin; C R Helsby; C C Evans; D M Chapman
Journal:  Br Med J       Date:  1976-11-13

3.  Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

Authors:  J N Fiessinger; M Schäfer
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

4.  Thromboangiitis obliterans--an autoimmune disorder?

Authors:  J A Spittell
Journal:  N Engl J Med       Date:  1983-05-12       Impact factor: 91.245

5.  Buerger's disease in the modern era.

Authors:  J L Mills; L M Taylor; J M Porter
Journal:  Am J Surg       Date:  1987-07       Impact factor: 2.565

6.  Cellular sensitivity to collagen in thromboangiitis obliterans.

Authors:  R Adar; M Z Papa; Z Halpern; M Mozes; S Shoshan; B Sofer; H Zinger; M Dayan; E Mozes
Journal:  N Engl J Med       Date:  1983-05-12       Impact factor: 91.245

  6 in total
  5 in total

1.  Thromoboagiitis Obliterans (TAO).

Authors:  Ui-Jun Park; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

2.  Buerger's disease as an indicator of socioeconomic development in different societies, a cross-sectional descriptive study in the North-East of Iran.

Authors:  Bahare Fazeli
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

3.  The Wound Healing Effects of Iloprost in Patients with Buerger's Disease: Claudication and Prevention of Major Amputations.

Authors:  A Afsharfard; M Mozaffar; F Malekpour; A Beigiboroojeni; M Rezaee
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

4.  Buerger's disease (thromboangiitis obliterans): clinical features and assessment by colour duplex ultrasound.

Authors:  Kathryn Busch
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

5.  Thromboangiitis Obliterans: 110 Years Old and Little Progress Made.

Authors:  Jeffrey W Olin
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.